|
Volumn 17, Issue 11, 2010, Pages 807-815
|
Clinical and virological factors associated with hepatitis B virus reactivation in HBsAg-negative and anti-HBc antibodies-positive patients undergoing chemotherapy and/or autologous stem cell transplantation for cancer.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
HEPATITIS B ANTIBODY;
HEPATITIS B CORE ANTIGEN;
HEPATITIS B SURFACE ANTIGEN;
MONOCLONAL ANTIBODY;
RITUXIMAB;
VIRUS DNA;
AGED;
ARTICLE;
BLOOD;
DRUG THERAPY;
FEMALE;
GENETICS;
GENOTYPE;
HEPATITIS B;
HEPATITIS B VIRUS;
HUMAN;
ISOLATION AND PURIFICATION;
MALE;
MIDDLE AGED;
MORTALITY;
NEOPLASM;
PROMOTER REGION;
STEM CELL TRANSPLANTATION;
TREATMENT OUTCOME;
VIRUS ACTIVATION;
AGED;
ANTIBODIES, MONOCLONAL, MURINE-DERIVED;
ANTINEOPLASTIC AGENTS;
DNA, VIRAL;
DRUG THERAPY;
FEMALE;
GENOTYPE;
HEPATITIS B;
HEPATITIS B ANTIBODIES;
HEPATITIS B CORE ANTIGENS;
HEPATITIS B SURFACE ANTIGENS;
HEPATITIS B VIRUS;
HUMANS;
MALE;
MIDDLE AGED;
NEOPLASMS;
PROMOTER REGIONS, GENETIC;
STEM CELL TRANSPLANTATION;
TREATMENT OUTCOME;
VIRUS ACTIVATION;
|
EID: 78651477247
PISSN: None
EISSN: 13652893
Source Type: Journal
DOI: 10.1111/j.1365-2893.2009.01239.x Document Type: Article |
Times cited : (82)
|
References (0)
|